Tenofovir versus entecavir on recurrence and mortality of hepatitis B virus-related hepatocellular carcinoma after curative therapy-Reference-Cited by-同舟云学术

Tenofovir versus entecavir on recurrence and mortality of hepatitis B virus-related hepatocellular carcinoma after curative therapy

Published:2024-08 Issue:8 Volume:123 Page:891-898
ISSN:0929-6646
Container-title:Journal of the Formosan Medical Association
language:en
Short-container-title:Journal of the Formosan Medical Association

Author:

Chang Kai-Chun,Su Tung-Hung,Liao Sih-Han^ORCID,Tseng Tai-Chung,Huang Shang-Chin^ORCID,Hsu Shih-Jer,Hong Chun-Ming,Liu Chen-Hua,Yang Hung-Chih,Liu Chun-Jen,Kao Jia-Horng^ORCID

Funder

National Taiwan University Hospital

Ministry of Health and Welfare

National Science and Technology Council

Publisher

Elsevier BV

Reference34 articles.

1. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021: accountability for the global health sector strategies 2016–2021: actions for impact: web annex 2: data methods;World Health,2021

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA A Cancer J Clin,2018

3. Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort study;Wu;Gastroenterology,2014

4. Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients;Su;Liver Int,2016

5. Distinct relapse rates and risk predictors after discontinuing tenofovir and entecavir therapy;Su;J Infect Dis,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-spectral and docking assessments to explore the combination of an antiviral drug, entecavir with bovine serum albumin;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2024-12

2. Highlights;Journal of the Formosan Medical Association;2024-08